AI Optics
FDA-cleared handheld retina camera with on-device AI screening for diabetic retinopathy, AMD, and glaucoma.
The Sentinel Camera is a solid FDA-cleared handheld imager, but its AI diagnostic software is still investigational. If you need cleared AI today, look at EyeArt or IDx-DR. For pilots and research evaluating an integrated multi-disease device, AI Optics is worth a close look.
Verified 6d ago · liveness 60/100 · cite: rightaichoice.com/tools/ai-optics
- Primary care clinics integrating retinal screening into routine checkups
- Retail health chains offering preventive vision services
- Long-term care facilities monitoring residents for diabetic retinopathy
- Health systems piloting scalable, portable teleophthalmology programs
- Patients needing full diagnostic workups—screening only, no confirmation
- Specialist-grade clinical research requiring high-resolution imaging beyond fundus
- Deployments outside FDA-regulated markets—currently US-only cleared
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip AI Optics if you need a fully FDA-cleared AI screening solution today—the AI software is still investigational. If you require cleared AI for immediate clinical use, consider EyeArt or IDx-DR instead.
The pricing is not published. AI Optics likely targets health systems and clinics that can invest in specialized diagnostic equipment. Compared to some alternatives that may offer software-only solutions, AI Optics bundles hardware and software, which could be a higher upfront cost but potentially lower per-screening cost. Without clear pricing, you should contact sales for a quote.
In short
AI Optics — FDA-cleared handheld retina camera with on-device AI screening for diabetic retinopathy, AMD, and glaucoma. Best for Primary care clinics integrating retinal screening into routine checkups, Retail health chains offering preventive vision services, Long-term care facilities monitoring residents for diabetic retinopathy. Contact Sales pricing.
What's new in AI Optics
Checked 3 days agoAcross the latest 1 update: 1 launch.
What people actually say about AI Optics — is it worth it?
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
16 mentions across 2 sources (Hacker News, Lemmy) · researched Jul 3, 2026.
- +Handheld form factor enables screening at any point of care.
- +FDA-cleared hardware inspires more confidence than purely software-only tools.
- +Targets three major eye diseases: DR, AMD, and glaucoma.
- +Designed for non-specialist use, lowering training requirements.
- +Proprietary optical technology aims for high-quality fundus images.
- −No proven community satisfaction — zero user reviews or discussions exist.
- −AI diagnostic software lacks FDA clearance (Sentinel Pro).
- −Pricing is opaque, complicating cost-benefit analysis without a quote.
- −No integration details published for common EHR or practice management systems.
- −No published clinical validation studies or peer-reviewed evidence found.
- • Unknown per-scan fees that may add up in high-volume settings
- • Potential upgrade costs for Sentinel Pro when it receives full FDA clearance
Viability Score
How well maintained and how widely used is AI Optics? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: August 2026
How we score →Key Features
- FDA-cleared Sentinel Camera handheld fundus imager
- Proprietary optical technology for retinal imaging
- On-device AI screening for diabetic retinopathy (investigational)
- On-device AI screening for age-related macular degeneration (investigational)
- On-device AI screening for glaucoma (investigational)
- No cloud connectivity required for AI analysis
- HIPAA-compliant data handling
- Portable design for point-of-care use
- Designed for non-specialist providers
- Suitable for primary care, optometry, retail health, long-term care
About AI Optics
AI Optics builds point-of-care diagnostic tools that let non-specialists screen for blinding eye diseases without a referral. Its flagship product, the Sentinel Camera, is an FDA-cleared handheld fundus imager engineered with proprietary optical technology. Designed for primary care, optometry, retail health, and long-term care settings, it captures digital images of the retina on the spot, eliminating the convenience and cost barriers that keep patients from seeing specialists. The system pairs the camera with Sentinel Pro, an investigational on-device AI software module that screens for diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. Because the AI runs locally on the device, there is no cloud upload, which supports HIPAA-compliant data handling and delivers instant results at the point of care. This integrated hardware-software approach is built to be simple to use, easy to implement, and cost-effective for providers. Important caveat: while the Sentinel Camera hardware received FDA 510(k) clearance in January 2025, Sentinel Pro is not yet cleared and is currently for investigational use only. That means today's deployments are limited to pilot programs and research settings, not broad clinical diagnostic use. Compared to software-only solutions like EyeArt or IDx-DR, AI Optics differentiates itself with a single portable device that combines imaging and multi-disease AI. But until Sentinel Pro wins FDA clearance, it remains a promising pilot option rather than a ready-to-deploy diagnostic tool.
Behind the Verdict
AI Optics is a genuinely interesting bet for providers who want to move eye screening out of the specialist's office and into everyday care. The Sentinel Camera's FDA clearance in January 2025 is real progress, and the handheld design plus on-device AI is a smart combination for low-resource settings. But here's the honest catch: the camera alone only captures images. The diagnostic value comes from Sentinel Pro, which is not FDA-cleared and is marked investigational only. That means right now you can't deploy this system to actually diagnose patients—it's for pilots, research, and gathering evidence. If you have an immediate need for cleared AI screening, EyeArt or IDx-DR are safer choices. What makes this appealing is the integrated approach. One device does imaging and AI analysis across multiple diseases, which could be a workflow win once clearance lands. For a retail clinic or health system pilot, that's a strong value proposition. But you'll need to factor in that regulatory uncertainty into your timeline. In practice, expect to invest in training and workflow integration—any point-of-care device only helps if staff actually use it. And while the on-device processing is a HIPAA-friendly plus, you'll still need a secure workflow for storing and transferring images. Bottom line: pick this if you're running a pilot or research study and want to evaluate an integrated hardware-software platform. Pass if you need cleared AI diagnostic capability today. Watch for Sentinel Pro's FDA status—that's the make-or-break.
Researching AI Optics? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas AI Optics actually fits — and what changes day-one when you adopt it.
During a routine physical for a diabetic patient, you use the Sentinel Camera to capture a retinal image and run the on-device AI screening (investigational) to check for diabetic retinopathy.
Outcome: You get an immediate result that can guide referral decisions, potentially reducing wait times and improving patient follow-through.
You offer a retinal screening service using Sentinel Camera, and use Sentinel Pro (in a pilot) to screen for AMD and glaucoma in addition to standard exams.
Outcome: You expand your preventive services and may detect conditions earlier, differentiating your clinic in the retail market.
You deploy Sentinel Camera to screen residents for diabetic retinopathy on-site, without needing to transport them to specialists.
Outcome: You improve access to eye care for a vulnerable population, and the on-device AI (if cleared) could alert you to those needing specialist review.
Use Cases
- Screen diabetic patients for retinopathy during routine primary care visits.
- Enable optometrists in retail clinics to detect early signs of AMD.
- Provide portable eye screening at home health or long-term care facilities.
- Reduce specialist referral wait times by triaging suspicious findings at point of care.
Models Under the Hood
as of 2026-08-23
Limitations
- The Sentinel Camera hardware is FDA-cleared, but the Sentinel Pro AI software is not FDA-cleared and is currently only intended for investigational use.
- The device is intended for screening, not definitive diagnosis, and may miss subtle pathologies.
- No integration with EHRs or other platforms is documented.
as of 2026-08-11
Verification history
We have re-verified AI Optics 6 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-checked, vendor evidence unchanged
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
Free to cite with attribution — this page re-verifies continuously.
Where the pricing makes sense
The company stage and team size where AI Optics's pricing actually pencils out — and where peers do it cheaper.
The pricing is not published. AI Optics likely targets health systems and clinics that can invest in specialized diagnostic equipment. Compared to some alternatives that may offer software-only solutions, AI Optics bundles hardware and software, which could be a higher upfront cost but potentially lower per-screening cost. Without clear pricing, you should contact sales for a quote.
Setup time & first value
How long it actually takes to get something useful out of AI Optics — broken out by persona, not the marketing-page minute.
For a pilot or research deployment, expect to spend a day on staff training and device setup. The camera is handheld and designed for non-specialists, so onboarding should be straightforward. For broader clinical integration, you'll need to factor in workflow design and possibly EHR integration, which may take weeks to months.
Switching to or from AI Optics
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From manual fundus photography: AI Optics can replace a tabletop camera, offering portability and on-device screening. You'll need to validate the system in your clinical workflow and train staff on image capture and
- ↗To EyeArt or IDx-DR: If you need cleared AI software, you can switch to these alternatives, but you'll lose the integrated hardware design and may need to adapt to a software-only workflow.
Resources & Guides
Tutorials & Learning
Official links
Tools that pair well with AI Optics
Common stack mates teams adopt alongside AI Optics, with the specific reason each pairing earns its keep.
Featured Head-to-Head Comparisons
Ai Optics vs Codametrix
Choose AI Optics if you need portable, FDA-cleared eye disease screening for point-of-care settings like primary care or retail health. Choose CodaMetrix if you're a large health system seeking enterprise medical coding automation with proven 5:1 ROI and deep EHR integration. They solve completely different problems.
Ai Optics vs Isomorphic Labs
AI Optics and Isomorphic Labs serve entirely different markets—AI Optics is a point-of-care screening device for eye disease in clinical settings, while Isomorphic Labs is a pharma R&D AI platform for drug discovery. They are not direct competitors. A buyer should choose AI Optics for immediate deployable eye screening hardware/software, and Isomorphic Labs for deep pharma partnerships requiring AlphaFold-driven drug design. There is no overlap.
Ai Optics vs Rapidsos
RapidSOS and AI Optics serve completely different domains: one is an emergency response platform for 911 centers and enterprises, the other a portable eye screening device for healthcare. Choose RapidSOS if you need AI-enhanced dispatch and real-time emergency data integration; choose AI Optics if you need point-of-care retinal screening. They are not competitors.
Alternatives to AI Optics
View allViz.ai
AI care coordination platform with 50+ FDA-cleared algorithms for real-time disease detection.
Butterfly Network
Handheld whole-body ultrasound with AI guidance, single-probe design.
Frequently Asked Questions
Used AI Optics? Help shape our editorial sentiment research.